Andere Sprachen Singular Genomics Systems, Inc.

Aktien

A3CQ54

US82933R1005

OMIC

Markt geschlossen - Nasdaq Andere Börsenplätze 22:30:01 03.05.2024			% 5 Tage	% 1. Jan.
0,4131 ^USD	+3,28 %		+2,20 %	-10,22 %

21.03.	SINGULAR GENOMICS SYSTEMS, INC. : UBS bekräftigt seine neutrale Bewertung	ZM
18.03.	Transcript : Singular Genomics Systems, Inc., Q4 2023 Earnings Call, Mar 18, 2024

Andere Sprachen

Erhalten Sie Zugang zu allen Nachrichten über alle Unternehmen: Verpassen Sie keine profitable Anlagechance mehr!

100% kostenlose Registrierung

Singular Genomics to Report First Quarter 2024 Financial Results on May 14, 2024	01.05.
Similar Genomics Systems: Q4 Earnings Snapshot	18.03.
Earnings Flash (OMIC) SINGULAR GENOMICS SYSTEMS Posts Q4 Revenue $1.1M, vs. Street Est of $1.04M	18.03.
Singular Genomics Systems, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	18.03.
Singular Genomics Systems, Inc. Reports Earnings Results for the Fourth Quarter Ended December 31, 2023	18.03.
Singular Genomics Reports Recent Highlights and Fourth Quarter and Full Year 2023 Financial Results	18.03.
North American Morning Briefing : Investors -2-	18.03.
Singular Genomics to Report Fourth Quarter and Full Year 2023 Financial Results on March 18, 2024	04.03.
Singular Genomics Showcases New G4X™ Spatial Sequencer at AGBT and Announces Significant Advances in Throughput, Quality, and Usability for G4® Sequencing Platform	05.02.
Singular Genomics Unveils G4X™ Spatial Sequencer, Transforming the Landscape of In Situ Multiomic Analysis	05.02.
Singular Genomics Systems, Inc. Showcases New G4X? Spatial Sequencer at AGBT and Announces Significant Advances in Throughput, Quality, and Usability for G4 Sequencing Platform	05.02.
Singular Genomics Unveils G4X Spatial Sequencer, Transforming the Landscape of In Situ Multiomic Analysis	05.02.
Singular Genomics Systems, Inc. Provides Unaudited Revenue Guidance for the Fourth Quarter of 2023	08.01.
Singular Genomics Systems Expects 31% Growth in Q4 Revenue	08.01.
Singular Genomics Reports Instrument Shipments and Preliminary Unaudited Fourth Quarter 2023 Revenue	07.01.
Singular Genomics Reports Instrument Shipments and Preliminary Unaudited Fourth Quarter 2023 Revenue	07.01.
Similar Genomics Systems: Q3 Earnings Snapshot	14.11.
Earnings Flash (OMIC) SINGULAR GENOMICS SYSTEMS Posts Q3 Revenue $0.5M	14.11.
Singular Genomics Reports Recent Highlights and Third Quarter 2023 Financial Results	14.11.
Singular Genomics Systems, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	14.11.

Keine Ergebnisse zu dieser Suche

Alle Nachrichten Analystenempfehlungen Wichtige Fakten Insiders Transkripte Pressemitteilungen Offizielle Publikationen Andere Sprachen Trading-Ideen MarketScreener Artikel MarketScreener Analysen

Andere Sprachen Singular Genomics Systems, Inc.

Aktien

A3CQ54

US82933R1005

OMIC

Andere Sprachen

Filter